Size: 5 mg / 10 mg
Provides a distinct mechanism in obesity research. By mimicking amylin—a peptide co-secreted with insulin by pancreatic β-cells—Cagrilintide acts synergistically when co-administered with GLP-1 receptor mimetics.
Supply duration: 12 to 24 weeks continuous administration
Binds amylin receptors (AMYR1-3) and calcitonin receptors (CTR) in the area postrema of the brainstem. Delays gastric emptying, suppresses postprandial glucagon secretion, and signals central satiety via non-GLP-1 pathways.
PURITY CHECK
HPLC Chromatogram provided with every shipment.
ZERO FILLERS
Free of residual solvents, heavy metals, or unlisted buffers.
SECURE DELIVERY
Discreet, protective thermal packaging.
Cagrilintide targets amylin and calcitonin receptors in the brainstem, whereas Semaglutide targets GLP-1 receptors.
You can feel it in your focus, your recovery, and your daily rhythm.
Three simple steps for a desired outcome
Proper storage and handling of laboratory reagents in vial format is crucial for ensuring their effectiveness and reliability. To maintain their integrity, it's important to follow specific guidelines for temperature control, light exposure, and contamination prevention.
